Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
554 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
2 Recruiting Institut Paoli-Calmettes Pancreatic Neoplasms Database
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
3 Recruiting Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: mFLOX
4 Recruiting Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: NC-6004;   Drug: Gemcitabine
5 Not yet recruiting Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Radiation: neoadjuvant short course IMRT;   Radiation: IORT
6 Recruiting Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.
Condition: Pancreatic Neoplasms
Intervention: Radiation: stereotactic radiotherapy
7 Recruiting Analgesia and Pancreatic Cancer Surgery
Condition: Pancreatic Neoplasms
Interventions: Procedure: Epidural patient controlled analgesia;   Drug: Intravenous patient controlled analgesia
8 Recruiting SBRT Pre-operatively for Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Radiation: 5-fraction stereotactic body radiation therapy
9 Recruiting A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention:
10 Recruiting Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: Apatinib
11 Recruiting Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: CG200745 PPA;   Drug: Gemcitabine;   Drug: Erlotinib
12 Recruiting Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Condition: Pancreatic Tumor
Intervention: Procedure: suspected pancreatic tumor
13 Recruiting Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
Condition: Pancreatic Neoplasms (Locally Advanced Non-metastatic)
Interventions: Drug: nab-paclitaxel;   Radiation: 60Gy in 30#;   Radiation: 50.4Gy in 28#;   Drug: Nelfinavir;   Drug: Capecitabine;   Drug: Gemcitabine
14 Recruiting Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Device: The imaging biomarkers determined by MR-PET
15 Recruiting Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Radiation: Stereotactic Radiation
16 Recruiting Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Condition: Resectable Pancreatic Cancers
Interventions: Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Other: Sugical resection;   Drug: Adjuvant chemotheapy
17 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
Intervention:
18 Recruiting Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer Non-resectable
Interventions: Drug: Folfirinox;   Radiation: Stereotactic Body Radiation Therapy
19 Recruiting Onco-geriatric Database of Patients With Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
20 Recruiting BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients
Condition: Pancreatic Cancer
Interventions: Drug: BPM31510 Nanosuspension Injection;   Drug: Gemcitabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.